Abstract

The aim of the study was to analyze the consequence of silencing genes coding for the key subunits of the telomerase complex, i.e. TERT, TERC and TP1 in human breast cancer MCF7 and MDA-MB-231cells. The transfection was performed using Lipofectamine2000 and pooled siRNAs. The cytotoxic and/or antiproliferative effect of siRNA was measured by the SRB assay, the cell cycle was analysed by flow cytometry and DNA fragmentation by TUNEL analysis. Telomerase activity was assessed by TRAP, followed by PAGE and ELISA assays. Telomerase downregulation was also assessed using qPCR in order to estimate the changes in the expression profile of genes engaged in apoptosis. It was revealed that treatment of breast cancer cells with different siRNAs (100 nM) resulted in a cell type and time-dependent effects. The downregulation of telomerase subunits was followed by reduction of telomerase activity down to almost 60 % compared to control cells. However, a significant effect was only observed when the TERT subunit was downregulated. Its silencing resulted in a significant (p < 0.05) increase of apoptosis (over 10 % in MCF7 and about 5 % in MDA-MB-231 cells, corresponding to the Annexin V assay) and DNA fragmentation (almost 30 % in MCF7 and over 25 % in MDA-MB-231 cells). Interestingly, also several proapoptotic genes were induced after the downregulation of the key telomerase subunit, including Bax, Bik or caspase-1 and caspase-14, as well as NGFR and TNFSF10 which were upregulated twice and more.

Highlights

  • High telomerase activity in cancer cells is supposed to be responsible for unlimited divisions and postponing cell death and/or senescence

  • The analysis of telomerase activity after transfection revealed that in MCF7 cells, telomerase reverse transcriptase (TERT) targetting siRNA caused more than 50 % enzyme inhibition after 72 h

  • Downregulation of telomerase in combination with doxorubicin in breast cancer cells was shown to potentiate the cytotoxic effect of the drug [20]

Read more

Summary

Introduction

High telomerase activity in cancer cells is supposed to be responsible for unlimited divisions and postponing cell death and/or senescence. It was revealed in many studies that regulation of telomerase is a multifactorial process in mammalian cells, involving the expression of genes coding for telomerase subunits, post-translational protein–protein interactions and protein phosphorylation [3, 4]. Numerous proto-oncogenes and tumor suppressor genes are engaged in this mechanism. The complexity of telomerase control mechanisms is studied in the context of stem cells renewal, tumor development and ageing [5,6,7]. Due to important roles of telomerase in those processes it is of great interest to identify the enzyme regulators (tumor suppressors or oncogenes, etc.). Since numerous studies have shown a correlation between short telomere length and increased mortality, the telomerase expression/activity control appears to be one of the most

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call